Follow the エーザイ株式会社 stock price and the full insider trade history of the company, a publicly traded company based in Japan. Shares are quoted on the JP market, under the authority of EDINET (Japan FSA). Market capitalisation: €1,370.5bn. The latest transaction was filed on 21 July 2026 (Holding update). Among the most active insiders: BlackRock Japan Co., Ltd.. Every trade is openly available.
Analysts rate エーザイ株式会社 Buy (bullish), based on 14 analysts. Average price target: JP¥4,539.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
11 of 11 declarations
Eisai Co., Ltd. es una empresa farmacéutica japonesa centrada en la investigación y el desarrollo de medicamentos, en particular para enfermedades neurológicas. Cotiza en la Bolsa de Tokio bajo el símbolo XTKS.